In summary, the genetic inhibition of PCSK9 in liver cancer cells resulted in a decrease in cell viability and migration, an increase in the levels of intracellular lipids and led to high levels of lipid hydroperoxide. The gene discussed is PCSK9; the disease is liver cancer.